Endocrinology Advisor21 小时
Denosumab Treatment Duration Predicts T-Score Achievement in Osteoporosis
The likelihood of achieving target T-scores at the total hip and lumbar spine with denosumab depends on baseline BMD in postmenopausal women with osteoporosis.
News-Medical.Net10 小时
The Unexpected Effects of GLP-1 Medications on Women’s Health
Investigating GLP-1 RAs reveals their impact on women's health, addressing metabolic disorders, reproductive health, and ...
Zacks Investment Research on MSN8 小时
FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review
Dr. Reddy’s Laboratories RDY and partner, Alvotech ALVO, announced the FDA’s acceptance of a regulatory filing, seeking the ...
Scientific Research Publishing16 小时
Enhancing Prediction of Osteoporosis Using Supervised and Unsupervised Learning: New ...
Background: Osteoporosis is a serious health issue that can lead to severe clinical diseases, involving fractures. The ...
Puffy face, chicken legs, and blurry vision: How Sunita Williams will adapt to Earth's ...
Nasa astronauts Butch Wilmore and Sunita Williams returned to Earth after an extended nine-month stay in space, experiencing ...
For Dietitians on MSN7 小时
Top 5 Health Benefits of Collagen Powder
Collagen powder has become a popular supplement in the health and wellness world, and for... The post Top 5 Health Benefits ...
PipelineReview.com15 小时
Alvotech and Dr. Reddy’s Announce FDA Acceptance of Biologic License Application for ...
HYDERABAD, India & REYKJAVIK, Iceland I March 18, 2025 I Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with ...